We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Shoots for Late 2013 Launch of Generic of Teva’s Copaxone
Mylan Shoots for Late 2013 Launch of Generic of Teva’s Copaxone
February 28, 2012
Despite analyst doubts, Mylan is confident it can launch a generic version of Teva’s blockbuster multiple sclerosis (MS) treatment Copaxone in the second half of 2013 pending FDA approval and resolution of legal challenges.